Wolverine Trading
AVXL icon

Wolverine Trading’s Anavex Life Sciences AVXL Stock Holding History

Wolverine Trading’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.31M Buy
+151,500
New +$1.54M ﹤0.01% 2611
2025
Q2 		– Sell
-145,700
Closed -$1.27M – 4721
2025
Q1 		$1.27M Sell
145,700
-12,000
-8% -$113K ﹤0.01% 2030
2024
Q4 		$1.74M Buy
157,700
+126,100
+399% +$970K ﹤0.01% 2086
2024
Q3 		$179K Buy
31,600
+10,400
+49% +$60K ﹤0.01% 4158
2024
Q2 		$89.5K Sell
21,200
-12,000
-36% -$48.5K ﹤0.01% 4098
2024
Q1 		$169K Sell
33,200
-24,200
-42% -$136K ﹤0.01% 3877
2023
Q4 		$534K Buy
57,400
+15,500
+37% +$107K ﹤0.01% 2884
2023
Q3 		$274K Sell
41,900
-21,200
-34% -$169K ﹤0.01% 3393
2023
Q2 		$499K Buy
63,100
+11,400
+22% +$97.7K ﹤0.01% 2603
2023
Q1 		$430K Sell
51,700
-16,300
-24% -$163K ﹤0.01% 2646
2022
Q4 		$630K Sell
68,000
-4,100
-6% -$43.8K ﹤0.01% 2175
2022
Q3 		$703K Buy
72,100
+31,200
+76% +$329K ﹤0.01% 2287
2022
Q2 		$405K Sell
40,900
-13,600
-25% -$129K ﹤0.01% 2748
2022
Q1 		$669K Buy
+54,500
New +$670K ﹤0.01% 2888
2021
Q4 		– Sell
-36,300
Closed -$647K – 5782
2021
Q3 		$647K Buy
+36,300
New +$723K ﹤0.01% 3580

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wolverine Trading's AVXL Position: Q4 2024 in Review

Wolverine Trading sold out of Anavex Life Sciences (AVXL) in Q4 2024, closing a stake of 24,565 shares — an estimated $189K sold.

Wolverine Trading first reported a position in AVXL in Q2 2022 and held it in 4 quarters. The position peaked at $241K in Q3 2022. 168 funds tracked by Wall St. Rank hold AVXL as of Q4 2024.

  • Wolverine Trading reported no remaining Anavex Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 24,565 Anavex Life Sciences shares in Q4 2024, an estimated $189K.
  • Wolverine Trading first reported a position in Anavex Life Sciences in Q2 2022 and held it in 4 quarters.
  • Wolverine Trading's Anavex Life Sciences position peaked at $241K in Q3 2022.
  • 168 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.